How 100% Import Tariffs Will Reshape the U.S. Pharmaceutical Market
An in-depth forecast examining the downstream effects on drug pricing, domestic manufacturing incentives, global supply chains, and competitive positioning for major pharmaceutical companies operating in the U.S. market.
Pfizer 2026 Competitive Intelligence Report
Pipeline & portfolio analysis covering therapeutic strategy, patent cliffs, and competitive positioning across oncology, immunology, and rare disease.
Roche 2026 Competitive Outlook
Balancing aging blockbuster biologics with new growth drivers and an ambitious pipeline across diagnostics and therapeutics.
GSK 2026 Competitive Intelligence Report
Evaluating GSK's post-demerger strategy, vaccine franchise strength, and pipeline momentum in respiratory and infectious disease.
Novo Nordisk 2026 Competitive Outlook
GLP-1 dominance, obesity market expansion, and the competitive threats reshaping the cardiometabolic landscape.
AstraZeneca 2026 Competitive Intelligence Report
Oncology-led growth, ADC pipeline analysis, and strategic positioning across key therapeutic areas and global markets.
FDA Accelerated Approval Pathway: 2026 Landscape & Trends
Tracking confirmatory trial requirements, withdrawal patterns, and how sponsors are navigating post-marketing commitments.